Literature DB >> 7959696

Trinucleotide (CAG) repeat expansion in chromosomes of Spanish patients with Huntington's disease.

J Benitez1, E Fernandez, P Garcia Ruiz, M Robledo, C Ramos, J Yébenes.   

Abstract

Huntington's disease (HD) is a neurodegenerative and hereditary disease characterized by progressive movement disorders and mental and behavioral abnormalities. The HD gene is an expanding and unstable trinucleotide repeat (CAG repeat sequences). We studied 77 individuals from 38 families with HD in an attempt to obtain information for genetic counselling and differential diagnosis. Our results indicate that individuals with more than 40 repeats will be affected by the disease, whereas those with fewer than 30 will be healthy. There can be some overlap between 30 and 40 repeats, and one should be careful when interpreting these results.

Entities:  

Mesh:

Year:  1994        PMID: 7959696     DOI: 10.1007/BF00211028

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  9 in total

1.  [DNA markers linked to Huntington's disease (D4S10 and D4S95) in Spanish families: preliminary results].

Authors:  J Benítez; C Ramos; E Fernández; C Ayuso; J Yébenes
Journal:  Rev Clin Esp       Date:  1992-04       Impact factor: 1.556

2.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

Authors: 
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

3.  Analysis of the huntingtin gene reveals a trinucleotide-length polymorphism in the region of the gene that contains two CCG-rich stretches and a correlation between decreased age of onset of Huntington's disease and CAG repeat number.

Authors:  D C Rubinsztein; D E Barton; B C Davison; M A Ferguson-Smith
Journal:  Hum Mol Genet       Date:  1993-10       Impact factor: 6.150

4.  A simple non-radioactive method for diagnosis of Huntington's disease.

Authors:  J M Valdes; D A Tagle; L W Elmer; F S Collins
Journal:  Hum Mol Genet       Date:  1993-06       Impact factor: 6.150

5.  The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease.

Authors:  S E Andrew; Y P Goldberg; B Kremer; H Telenius; J Theilmann; S Adam; E Starr; F Squitieri; B Lin; M A Kalchman
Journal:  Nat Genet       Date:  1993-08       Impact factor: 38.330

6.  Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease.

Authors:  R G Snell; J C MacMillan; J P Cheadle; I Fenton; L P Lazarou; P Davies; M E MacDonald; J F Gusella; P S Harper; D J Shaw
Journal:  Nat Genet       Date:  1993-08       Impact factor: 38.330

7.  Dynamic mutation in Dutch Huntington's disease patients: increased paternal repeat instability extending to within the normal size range.

Authors:  K E De Rooij; P A De Koning Gans; M I Skraastad; R D Belfroid; M Vegter-Van Der Vlis; R A Roos; E Bakker; G J Van Ommen; J T Den Dunnen; M Losekoot
Journal:  J Med Genet       Date:  1993-12       Impact factor: 6.318

8.  A study of the Huntington's disease associated trinucleotide repeat in the Scottish population.

Authors:  L H Barron; J P Warner; M Porteous; S Holloway; S Simpson; R Davidson; D J Brock
Journal:  J Med Genet       Date:  1993-12       Impact factor: 6.318

9.  Trinucleotide repeat elongation in the Huntingtin gene in Huntington disease patients from 71 Danish families.

Authors:  A Nørremølle; O Riess; J T Epplen; K Fenger; L Hasholt; S A Sørensen
Journal:  Hum Mol Genet       Date:  1993-09       Impact factor: 6.150

  9 in total
  5 in total

1.  The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size.

Authors:  R R Brinkman; M M Mezei; J Theilmann; E Almqvist; M R Hayden
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

2.  Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice.

Authors:  Wenzhen Duan; Zhihong Guo; Haiyang Jiang; Melvin Ware; Xiao-Jiang Li; Mark P Mattson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-14       Impact factor: 11.205

3.  Huntington's disease: confirmation of diagnosis and presymptomatic testing in Spanish families by genetic analysis.

Authors:  A Sánchez; S Castellví-Bel; M Milà; D Genis; M Calopa; D Jiménez; X Estivill
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-12       Impact factor: 10.154

4.  Impaired PLP-dependent metabolism in brain samples from Huntington disease patients and transgenic R6/1 mice.

Authors:  M Alba Sorolla; María José Rodríguez-Colman; Núria Vall-Llaura; Celia Vived; Marta Fernández-Nogales; José J Lucas; Isidre Ferrer; Elisa Cabiscol
Journal:  Metab Brain Dis       Date:  2015-12-14       Impact factor: 3.584

5.  Somatic stability in chorionic villi samples and other Huntington fetal tissues.

Authors:  J Benitez; M Robledo; C Ramos; C Ayuso; R Astarloa; J Garcia Yébenes; B Brambati
Journal:  Hum Genet       Date:  1995-08       Impact factor: 4.132

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.